An Open Study of Clozapine in the Treatment of Resistant Schizophrenia
نویسندگان
چکیده
This open study was undertaken to assess the efficacy of clozapine in resistant schizophrenics, its side effects and safety profile and the mean dose required. Sample consisted of 28 patients who had been previously treated with neuroleptics and ECTs. A special proforma was prepared for recording the psychopathology and side effect profile. The complete blood count, differential count and BPRS scores were recorded weekly for a period of 3 months. Within 1 month of treatment on a dose range of 100-200 mg/day a 25%-50% decline in the BPRS score was noticed, the mean dose required was 241 mg/day. Sedation and sialorrhoea constituted the commonest side effects in 90% patients. No case of agranulocytosis was reported. The implications of the study are discussed.
منابع مشابه
کاربرد داده های EEG به عنوان شاخص پیش بینی اثربخشی کلوزاپین دردرمان بیماران مبتلا به اسکیزوفرنی مقاوم به درمان
Background and purpose: EEG is used as a diagnostic tool in the diagnosis and prognosis of disease spread. Among the psychiatric illnesses that can utilize EEG to measure response to treatment, schizophrenia can be noted. Many investigations on the application of data EEG as a predictor of treatment response in patients with schizophrenia refractory to clozapine has been done in order to res...
متن کاملLow Dose Celecoxib Combined with Clozapine for Treatment of Schizophrenia: A Double Blind Randomized Clinical Trial
Introduction: Higher levels of pro-inflammatory cytokines in schizophrenia have suggested that dysfunctions of the immune system may play a role in this disabling condition. The current study was performed to discover if low dose celecoxib combined with clozapine may improve symptoms of schizophrenia or not. Methods:<span...
متن کاملبررسی مقایسه ای تاثیر کلوزاپین، الکتروشوک (ECT) و ترکیب آن دو در بیماران اسکیزوفرنیا مقاوم به درمان
Background and purpose: In spite of discovering new antipsychotics in the past years, many patients of schizophrenia don’t response to none of them and are resistance to treatment. In this case, clozapine, ECT or some combination of drug mostly be used, but there are many patients of schizophrenia who are resistance to them. In recent years, of combination of ECT and clozapine has been sugges...
متن کاملبررسی عوارض جانبی کلوزاپین در مراحل مختلف درمان در نمونه ای از بیماران اسکیزوفرنیک مقاوم به درمان
Background and purpose:Çlozapine is an antipsychotic with the least extrapyramidal side effects and more agranulositosis than typical antipsychotics. Çlozapine has the unique effects on the treatment-resistant schizophrenia but with threatening side effects on the patients. Thus we did this prospective study in order to identufy the side effects of clozapine in Ïranian treatment-resistant sch...
متن کاملSerum TNF-α, IL-10 and IL-2 in Schizophrenic Patients Before and After Treatment with Risperidone and Clozapine
Background: Schizophrenia is a disorder of the executive function of both sensory and central nervous system. Recent studies suggest that immune mechanisms play a role in the pathophysiology of this disease. The variations in cytokine concentrations have been associated with psychopathology and treatment of schizophrenia. Objective: To investigate the changes in serum concentrations of TNF- α, ...
متن کاملگزارش یک مورد آگرانولوسیتوز بدنبال مصرف کلوزاپین
Introduction : clozapine is the first effective antipsychotic drug with the least extra pyramidal side effects and more agranulocytosis than other standard neuroleptics. Granolocytopenia or agranulocytosis occurs in 1 to 2 percent of all patients treated with clozapine. agranulocytosis due to clozapine is a fatal disorder that requires immediate clinical intervention. Method : this paper re...
متن کامل